publication . Article . 2005

Síndrome de Déficit Atencional: antecedentes neurobiológicos y cognitivos para estudiar un modelo de endofenotipo

Francisco Aboitiz; Carolina Schröter G;
Open Access Spanish
  • Published: 01 Mar 2005
  • Publisher: Sociedad de Neurología, Psiquiatría y Neurocirugía
Abstract
Este artículo es una breve actualización en cuanto a las bases cognitivas del Síndrome de Déficit Atencional e Hiperactividad (SDAH). Presentamos algunos resultados recientes en que analizamos estrategias cognitivas y el efecto neuro.siológico de psicoestimulantes en esta condición. Esbozamos un modelo basado en resultados nuestros y de otros grupos, en el cual la estrategia atencional de los sujetos con SDAH se caracteriza por un amplio marco espacial y una corta ventana temporal en comparación a los controles. Por último, proponemos líneas de investigación básico-clínica respecto de ese síndrome . This article is a brief update on the cognitive bases of Attent...
Subjects
free text keywords: Attention Deficit Hiperactivity Disorder, dopamine, methylphenidate, evoked potentials, Síndrome de Déficit Atencional e Hiperactividad, dopamina, metilfenidato, potenciales evocados, Humanities, Philosophy
25 references, page 1 of 2

1. Sagvolden T, Johansen E, Aase H, Russell VA. A dynamic developmental theory of Attention-Deficit /Hyperactivity Disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behavioral and Brain Sciences 2005; en prensa

2. American Academy of Pediatrics Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Am Acad Pediatrics. Pediatrics 2000; 105: 1158-1170

3. Taylor E. Clinical foundations of hyperactivity research. Behav Brain Res 1998; 94: 11-24

4. Cantwell DP. Attention deficit disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1996; 35: 978-987

5. Muglia P, Jain U, Macciardi F, Kennedy JL. Adult attention deficit hyperactivity disorder and the dopamine D4 receptor gene. Am J Med Genet 2000; 96: 273-277

6. Barkley RA. Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. J Clin Psychiatry 2002; 63 Suppl 12: 10-15

7. Slaats-Willemse D, Swaab-Barneveld H, de Sonneville L, van der Meulen E, Buitelaar J. Deficient response inhibition as a cognitive endophenotype of ADHD. J Am Acad Child Adolesc Psychiatry 2003; 42: 1242-1248 [OpenAIRE]

8. Castellanos FX, Tannock R. Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci 2002; 3: 617-628. Review

9. Conners CK. Forty years of methylphenidate treatment in attention-deficit/hyperactivity disorder. J Atten Disord 2002; 6 Suppl 1: 17- 30

10. Volkow ND, Wang GJ, Fowler JS, Telang F, Maynard L, Logan J, et al. Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. Am J Psychiatry 2004; 161: 1173-1180

11. Andreasen N, Black D. Introductory textbook of psychiatry. Washington: Am Psychiatry Press, 1995

12. Kollins SH. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient. J Clin Psychiatry 2003; 64 Suppl 11: 14-18

13. Faraone SV, Wilens T. Does stimulant treatment lead to substance use disorders? J Clin Psychiatry 2003;64 Suppl 11: 9-13 [OpenAIRE]

14. Aboitiz F, Montiel J.Anatomy of “mesencephalic” dopaminergic cell groups in the central nervous system. In: Segura J, editor. Role of Reactive Catecholamine Species in Neurodegeneration and Apoptosis of Dopaminergic Neurons. New York: FP Graham, 2001. p. 1-19

15. Sagvolden, T, Aase H, Zeiner P, Berger DF. Altered reinforcement mechanisms in attentiondeficit/hyperactivity disorder. Behav Brain Res 1998; 94: 61-71

25 references, page 1 of 2
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue